Form 4: Organon & Co. Director Martha E. McGarry Reports Phantom Stock Acquisition
SEC Form 4
Director Martha E. McGarry reports acquisition of phantom stock units in Organon & Co. through a dividend reinvestment and the Non-Employee Director Savings Plan.
Summary
- Martha E. McGarry, a director of Organon & Co., reported a transaction involving phantom stock units.
- On June 7, 2024, McGarry acquired 9,638.554 phantom stock units under the Organon Non-Employee Director Savings Plan.
- These units are economically equivalent to shares of Organon common stock on a 1-for-1 basis.
- The phantom stock units are payable in cash upon settlement after McGarry's termination of service as a director.
- The price of the phantom stock was $20.75.
- Following the reported transaction, McGarry beneficially owns 36,454.813 derivative securities.
- Holdings include phantom stock acquired in dividend reinvestment transactions on June 15, 2023, September 14, 2023, December 14, 2023 and March 14, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reflects a standard insider transaction. The director's participation in the savings plan is a mildly positive signal.
Positives
- The director's participation in the Non-Employee Director Savings Plan and dividend reinvestment plan demonstrates confidence in the company's future.
Industry Context
This filing is a routine disclosure related to insider transactions and provides insight into director compensation and investment in the company's stock.
Comparison to Industry Standards
- Director compensation packages often include stock or stock-based awards to align their interests with those of shareholders.
- Phantom stock units are a common form of equity compensation, particularly for non-employee directors.
- The specifics of the Organon Non-Employee Director Savings Plan would need to be compared to similar plans at peer companies to assess its competitiveness.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it signals director confidence in the company.
Key Dates
| Date | Description |
|---|---|
| June 15, 2023 | Phantom stock acquired in dividend reinvestment transactions |
| September 14, 2023 | Phantom stock acquired in dividend reinvestment transactions |
| December 14, 2023 | Phantom stock acquired in dividend reinvestment transactions |
| March 14, 2024 | Phantom stock acquired in dividend reinvestment transactions |
| June 7, 2024 | Transaction date for the acquisition of 9,638.554 phantom stock units |
| June 11, 2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.